| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12,2 M € | -10.4% | 13,6 M € | -3.2% | 14,1 M € | +0.5% | 14,0 M € | +7.8% | 13,0 M € | -4.0% | 13,5 M € | -8.1% | 14,7 M € | +12.4% | 13,1 M € | -1.7% | 13,3 M € | -2.5% | 13,7 M € | -3.1% | 14,1 M € | -10.2% | 15,7 M € | +4.5% | 15,0 M € | -17.7% | 18,2 M € | +31.5% | 13,9 M € | +5.4% | 13,2 M € | -3.6% | 13,7 M € | |
| EBITDA | 494,8 k € | +3.1% | 480,2 k € | -10.4% | 535,7 k € | -73.7% | 2,0 M € | +23.9% | 1,6 M € | -20.9% | 2,1 M € | -10.1% | 2,3 M € | +178.3% | 828,6 k € | +21.6% | 681,1 k € | +578.4% | 100,4 k € | -46.0% | 185,9 k € | +128.3% | -656,3 k € | -188.0% | 745,7 k € | +90.7% | 391,0 k € | -46.8% | 734,4 k € | +76.3% | 416,5 k € | +256.7% | -265,8 k € | |
| Operating profit | 473,6 k € | -33.7% | 714,4 k € | +26.8% | 563,4 k € | -71.8% | 2,0 M € | +14.7% | 1,7 M € | -17.4% | 2,1 M € | -0.4% | 2,1 M € | +181.3% | 753,4 k € | +25.9% | 598,3 k € | +759.7% | 69,6 k € | -41.4% | 118,8 k € | +124.1% | -493,9 k € | -174.6% | 662,0 k € | +231.9% | 199,5 k € | -69.8% | 660,2 k € | +116.4% | 305,1 k € | +180.6% | -378,8 k € | |
| Profit/loss | 333,1 k € | -42.2% | 576,6 k € | +27.4% | 452,6 k € | -69.3% | 1,5 M € | +14.4% | 1,3 M € | -17.1% | 1,6 M € | +6.2% | 1,5 M € | +235.3% | 437,2 k € | +45.5% | 300,5 k € | +1154.7% | 24,0 k € | -97.4% | 922,2 k € | +338.0% | -387,4 k € | -162.1% | 623,6 k € | +181.8% | 221,3 k € | +20.3% | 184,0 k € | +190.7% | -202,9 k € | +66.7% | -610,2 k € | |
| Equity | 2,0 M € | -48.4% | 4,0 M € | +17.1% | 3,4 M € | +15.5% | 2,9 M € | +2.7% | 2,9 M € | +11.3% | 2,6 M € | +6.6% | 2,4 M € | -11.1% | 2,7 M € | +19.3% | 2,3 M € | +15.3% | 2,0 M € | +1.2% | 1,9 M € | +90.5% | 1,0 M € | -27.6% | 1,4 M € | +79.7% | 782,4 k € | +39.4% | 561,1 k € | +48.8% | 377,1 k € | -35.0% | 580,0 k € | |
| Total assets | 4,0 M € | -18.1% | 4,9 M € | -6.9% | 5,3 M € | +1.0% | 5,2 M € | +8.3% | 4,8 M € | -4.2% | 5,0 M € | +1.7% | 5,0 M € | +18.5% | 4,2 M € | +14.4% | 3,7 M € | +6.9% | 3,4 M € | -20.7% | 4,3 M € | -3.2% | 4,5 M € | -0.6% | 4,5 M € | +2.3% | 4,4 M € | -29.4% | 6,2 M € | -0.9% | 6,3 M € | +0.2% | 6,2 M € | |
| Cash | 237,1 k € | -22.5% | 305,8 k € | +36.1% | 224,6 k € | +0.4% | 223,7 k € | +18.3% | 189,0 k € | +6.5% | 177,4 k € | +42.0% | 125,0 k € | -60.2% | 313,7 k € | +122.6% | 140,9 k € | +13.1% | 124,6 k € | +9.9% | 113,4 k € | -48.0% | 218,0 k € | -5.0% | 229,4 k € | -47.8% | 439,8 k € | +18.8% | 370,2 k € | -4.3% | 386,7 k € | -14.9% | 454,6 k € | |
| Debts | 1,9 M € | +121.8% | 838,5 k € | -51.2% | 1,7 M € | -18.3% | 2,1 M € | +17.3% | 1,8 M € | -18.5% | 2,2 M € | -2.3% | 2,3 M € | +185.0% | 790,0 k € | +15.0% | 686,7 k € | +5.6% | 650,3 k € | -55.5% | 1,5 M € | -40.3% | 2,5 M € | +31.8% | 1,9 M € | -7.5% | 2,0 M € | -39.8% | 3,3 M € | -26.0% | 4,5 M € | +1.7% | 4,4 M € | |
| Staff | 25,9 | 25,8 | 26,2 | 28,4 | 27,9 | 29,4 | 31,9 | 46,5 | 46,5 | 49,9 | 52,2 | 51,6 | 52,8 | 72,9 | 91,3 | 98,9 | 125 | |||||||||||||||||
Public limited company · Liège · incorporated on 26/03/1925 · 25,9 ETP
Public limited company profitable and well capitalised. Cash position declining (-22.5%).
Solid counterparty for a standard engagement.
LABORATOIRES LOHMANN & RAUSCHER is a Public limited company incorporated in 1925. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Liège. It employs on average 25,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette